Table 2 Odds ratios and 99% confidence intervals for association between three components of the metabolic syndrome and clinical bilirubin levels
From: Bilirubin as an indicator of cardiometabolic health: a cross-sectional analysis in the UK Biobank
Bilirubin cut-off (μmol/L) | N (men/women) | Men | Women | |||
|---|---|---|---|---|---|---|
OR (99% CI) | P trend | OR (99% CI) | P trend | |||
Adjusted models | ||||||
WC | ||||||
 Ref. |  < 10 | 128,981/205,724 | – |  < 0.001 | – |  < 0.001 |
 1 | 10–17 | 68,710/39,020 | 0.80 (0.78 to 0.83) | 0.73 (0.70 to 0.75) | ||
 2 |  ≥ 17.1 | 15,862/8,223 | 0.68 (0.65 to 0.72) | 0.54 (0.50 to 0.58) | ||
TG | ||||||
 Ref |  < 10 | 129,224/206,137 | – |  < 0.001 | – |  < 0.001 |
 1 | 10–17 | 68,802/39,078 | 0.65 (0.63 to 0.66) | 0.62 (0.59 to 0.64) | ||
 2 |  ≥ 17.1 | 15,874/8,230 | 0.58 (0.55 to 0.60) | 0.52 (0.48 to 0.56) | ||
SBP | ||||||
 Ref. |  < 10 | 121,051/192,488 | – |  < 0.001 | – |  < 0.001 |
 1 | 10–17 | 64,434/36,713 | 0.90 (0.88 to 0.93) | 0.91 (0.88 to 0.94) | ||
 2 |  ≥ 17.1 | 14,965/7,769 | 0.87 (0.82 to 0.92) | 0.89 (0.83 to 0.96) | ||
DBP | ||||||
 Ref. |  < 10 | 121,052/192,493 | – |  < 0.001 | – |  < 0.001 |
 1 | 10–17 | 64,439/36,714 | 1.00 (0.98 to 1.03) | 0.95 (0.92 to 0.99) | ||
 2 |  ≥ 17.1 | 14,965/7,769 | 0.94 (0.89 to 0.98) | 0.88 (0.83 to 0.95) | ||